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a b s t r a c t
Objectives: To determine the phenotypic and molecular characteristics of Enterococcus fae-
calis recovered from primary endodontic infections in Brazilian patients.
Methods: Twenty isolates of E. faecalis recovered from 43 Brazilian patients with primary
endodontic infections were identified by biochemical profiling (API20Strep) and 16S rDNA
sequencing. Antimicrobial susceptibility was ascertained by agar dilution, using the recom-
mended protocol of the Clinical and Laboratory Standards Institute (CLSI). PCR with
validated primers was used to detect genes associated with antibiotic resistance and specific
virulence factors.
Results: All isolates were deemed susceptible to penicillin G, erythromycin and vancomycin.
However, nine isolates had a minimum inhibitory concentration of 4 mg/mL to vancomycin
(the resistance breakpoint). Fourteen isolates (70% of isolates) were also resistant to
tetracycline with MICs of >64 mg/mL. PCR products for tetracycline resistance genes were
detected in test isolates, while erythromycin and vancomycin resistance genes were not
evident. Gelatinase, aggregation substance and enteroccocal surface protein genes were
detected in 20, 18 and 12 isolates, respectively.
Conclusions: Endodontic E. faecalis isolates exhibit high level of resistance to tetracycline, an
antibiotic that has use in local treatment of dental infections. This opens up a much-needed
debate on the role and efficacy of this antibiotic for oral infections. Furthermore, these
isolates were shown to possess genes that could contribute to pathogenicity in the pulp
cavity.
# 2013 Elsevier Ltd. All rights reserved.
Available online at www.sciencedirect.com
journal homepage: www.intl.elsevierhealth.com/journals/jden1. Introduction
The microbiome of primary and post treatment endodontic
infections has been extensively studied, although the main* Corresponding author at: Av Afranio de Mello Franco, 141/207 Leblon
E-mail addresses: ximenes@uerj.br, endodontia@renataximenes.co
0300-5712/$ – see front matter # 2013 Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.jdent.2013.07.004aetiological agents remain unclear. Ozok et al.1 suggested that
endodontic infections were more complex than previously
reported with more than 600 bacterial taxa associated with
infected root canals. Although a single aetiological agent is
unlikely, there is evidence supporting the association of, CEP 22430-060, Rio de Janeiro, RJ, Brazil. Tel.: +55 21 2294 8268.
m.br (R.X. Lins).
.
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and secondary endodontic infection.2–8
Enterococci are Gram-positive, coccus-shaped bacteria and
frequent colonisers of the human gastrointestinal and
genitourinary tracts. In the past, these bacteria were not
considered particularly virulent. However, recent years have
seen an increase in nosocomial infections caused by entero-
coccal species largely attributed to their antimicrobial resis-
tance profiles.9 Of the group, E. faecalis is considered the most
significant species, both in terms of frequency of isolation
from sites of infection and in the transfer of antibiotic
resistance.10
Enterococci are regarded as antibiotic-resistant, opportu-
nistic pathogens frequently recovered from patients who have
received multiple courses of antibiotics and who have been
hospitalized for prolonged periods. These bacteria exhibit
intrinsic resistance to several antibiotics, as well as an ability
to rapidly acquire antibiotic resistance. Enterococci are not
generally regarded as normal inhabitants of the oral cavity,
but may colonise transiently, particularly in debilitated
individuals.11 E. faecalis has, however, been isolated from a
range of oral conditions including carious lesions, chronic
periodontitis, and has been associated with persistent apical
periodontitis.12 E. faecalis has been detected primarily at sites
of persistent endodontic infections,9,13–15 and has also been
found in high numbers in some primary endodontic infec-
tions.7,8,16
Neither the source, nor the role of enterococci in the
pathogenesis of endodontic infections is understood.15,17 Oral
E. faecalis has been shown to possess a range of virulence
factors including gelatinase activity, expression of haemoly-
sin, response to pheromones, bacteriocin production, biofilm
development, expression of adherence factors, aggregation
substances and resistance to several antibiotics.12,18–21 Impor-
tantly, enterococci have been shown to transfer certain
virulence traits to related species in root canals ex vivo,
highlighting the need to more fully understand the role of
these pathogens in infection in general.22
Finally, it is not unrealistic to expect that enterococci
resistant to multiple antimicrobials may be able to colonise
the root canal environment. Although Vancomycin Resistant
Enterococci (VRE) have not been isolated in root canal
infections, Nandakumar et al.23 identified proteins from the
tet and van operons in all the patient cases where enterococci
were detected by genomic analysis of endodontic infections.
Additionally, in the patient sample from which the VanE
protein was identified, E. faecalis was highly prevalent. This is
important from a treatment perspective because antibiotics
are known not to be very effective in treating chronic or
localised acute endodontic infections or in preventing
recurrent episodes of infection. Besides, it is an alert to the
potential increase in antibiotic resistance amongst oral
isolates.
All this information justifies the isolation, identification
and characterisation of virulence factors and antimicrobials
resistant determinants of endodontic enterococci. Genetic
analysis can be used as an initial screening tool, and although
detection of the target gene itself does not necessarily mean
that the encoded protein will subsequently be expressed, it
does indicate the potential for expression.The aims of this study were therefore to analyse isolates of
E. faecalis from patients with primary endodontic infections for
the presence of defined virulence genes and susceptibility to
antibiotics commonly used in dentistry and other areas of
clinical importance. Through enhanced awareness of the
characteristics of E. faecalis involved in endodontic infection,
we can identify optimal treatment strategies to improve
patients’ health and potentially limit dissemination of
antimicrobial resistance.
2. Materials and methods
2.1. Patient selection and sample collection
A total of 43 patients with primary endodontic infection were
recruited with informed consent for participation in this
study. Only necrotic pulps without oral exposition were
included. All patients were otherwise healthy and had not
been hospitalised or had received antibiotics for at least 6
months prior to the study. Pregnancy or active periodontal
disease were additional exclusion criteria. The research was
approved by the Research Ethics Committee of Rio de Janeiro
State University (COEP051/2009).
After plaque removal and rubber dam isolation, the tooth
and the operative field was cleansed with 3% (v/v) hydrogen
peroxide and then disinfected with 2.5% NaOCl solution.
Coronal access was made using sterile round burs without
water spray. Samples were collected from the root canal using
a #15 H-type file (Dentsply/Maillefer, Ballaigues, Switzerland)
and two sterile paper points, as previously described.24 Both
file and paper points were then transferred to tubes containing
Enterococcosel broth (Becton Dickinson Microbiology Sys-
tems, MD, USA) and incubated for 48 h at 37 8C to selectively
recover enterococci. Isolated colonies were then subcultured
on to blood agar plates (Becton Dickinson Microbiology
Systems) and pure colonies subjected to identification tests.
A sterile paper point without previous contact with the root
canal was included in all sampling procedures and served as a
negative control.
2.2. Culture and identification of E. faecalis
All isolates were presumptively identified as enterococci based
on growth in the presence of bile and azide, and esculin
hydrolysis. Additional tests to further characterise these
isolates included Gram-staining, catalase activity, motility
testing, pyruvate fermentation, and an ability to grow in Tryptic
Soy Agar (Merk Darmstadt, DE) supplemented with 6.5% NaCl at
42 8C. A commercial biochemical profiling test (API 20 Strep
identification kit; Analytical Profile Index; bioMe´rieux SA,
Marcy-Etoile, France) was also used, and E. faecalis ATCC
29212 served as a positive control. The prevalence of E. faecalis
was recorded as the percentage of cases examined.
2.3. Confirmation of E. faecalis identity by sequencing of
16S ribosomal DNA
Total DNA was extracted using the PureLinkTM Genomic DNA
Mini Kit (Invitrogen, Paisley, UK) and the manufacturer’s
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for PCR using the universal bacterial 16S rRNA primer
pair of 27f and 1492r (Table 1). All PCRs were performed in a
50 mL final reaction volume containing 1 mM of each primer,
25 mL of PCR Master Mix (Promega, Madison, USA) and 2 mL
of total DNA template. Negative controls of sterile ultrapure
water in place of DNA template were included with each
PCR.
PCR was undertaken in a DNA thermocycler using an
initial denaturation step of 95 8C for 1 min, and then 26
thermal cycles of 94 8C for 45 s, 50 8C for 45 s and 72 8C for
1.5 min, followed by a final step of 72 8C for 15 min. Gel
electrophoresis of the amplicons was performed in a 1.0%
agarose gel at 60 V/cm2. PCR amplicons stained with safe
view dye (NBS Biologicals, Cambridgeshire, UK) were
subsequently detected by ultraviolet transillumination. A
100-bp DNA ladder (Promega) served as a molecular weight
standard.
Enterococcus species were then identified using Eurofins
MWG Operon’s sequencing service. Briefly, PCR products
were purified using the QIAquick PCR purification kit (Qiagen,
Hilden, Germany) and the DNA subjected to a sequencing PCR
reaction using the primer 357f (Table 1). The partial 16S rDNA
sequences obtained were then compared with those
sequences within the NCBI database using the Basic Local
Alignment Search Tool (BLAST). Sequences with 98–100%Table 1 – PCR details to detect antimicrobial resistance to eryth
vancomycin (vanA, vanB, vanC1, vanC2/3) and virulence-associ
(esp), cytolysin (cylB), and aggregation substance (agg, asa373).
Gene target(s) Primer Oligonucleotide sequence
16S RNA 27f
1492r
357f
GTGCTGCAGAGAGTTTGATCCTG
CACGGATCCTACGGGTACCTTGT
CTCCTACGGGCGGCAGCAG
erm(A) ERMA1
ERMA2
TCTAAAAAGCATGTAAAAGAA
CTTCGATAGTTTATTAATATTAGT
erm(B) ERMB1
ERMB2
GAAAAGGTACTCAACCAAATA
AGTAACGGTACTTAAATTGTTTC
tet(M) TETM1
TETM2
AGTTTTAGCTCATGTTGATG
TCCGACTATTTAGACGACGG
tet(L) TETL1
TETL2
CCTGCGAGTACAAACTGG
TCAAGGTAACCAGCCAAC
vanA VANA1
VANA2
GGGAAAACGACAATTGC
GTACAATGCGGCCGTTA
vanB VANB
VANB2
ATGGGAAGCCGATAGTC
GATTTGCTTCCTCGACC
vanC1 VANC1-1
VANC1-2
GGTATCAAGGAAACCTC
CTTCCGCCATCATAGCT
vanC2/3 VANC2/3-1
VANC2/3-2
CTCCTACGATTCTCTTG
CGAGCAAGACCTTTAAG
gelE GELE1
GELE2
ACGCATTGCTTTTCCATC
ACCCCGTATCATTGGTTT
esp ESP1
ESP2
TTGCTAATGCTAGTCCACGACC
GCGTCAACACTTGCATTGCCA
cylB CYLB1
CYLB2
ATTCCTACCTATGTTCTGTTA
AATAAACTCTTCTTTTCCAAC
agg AGG1
AGG2
AAGAAAAAGAAGTAGACCAAC
AAACGGCAAGACAAGTAAATA
asa373 ASA373F
ASA373R
GGACGCACGTACACAAAGCTACC
TGGGTGTGATTCCGCTGTAidentity to sequences deposited in the public domain
databases were considered to be positive identification of
taxa.
2.4. Antimicrobial susceptibility testing
The minimum inhibitory concentration (MIC) of E. faecalis
isolates against a range of antibiotics was determined by agar
dilution, using the recommendations of the Clinical and
Laboratory Standards Institute (CLSI). Briefly, Mu¨eller-Hinton
Agar (Difco, USA) plates were prepared with penicillin,
erythromycin, tetracycline and vancomycin microdilutions
and inoculated with a bacterial suspension equivalent to 0.5
McFarland standard and incubated at 37 8C for 18 h. Isolates
were considered susceptible or resistant according to break-
point values recommended by the CLSI document M100-S21
(Wayne, PA, USA).
2.5. Detection of antimicrobial resistance and virulence
genes
The DNA of all isolates was analysed for the presence of
antibiotic resistance genes including those for erythromycin,
tetracycline and vancomycin, and also for the virulence
associated genes of gelatinase, surface protein, cytolysin
and aggregation substance (Table 1).romycin (erm(A) and erm(B)), tetracycline (tet(M) and tet(L)),
ated genes gelatinase (gel(E)), enterococcal surface protein
 (50–30) Product size (bp) Tm (8C) Reference
GCTCAG
TACGACTT
1164 54 26,28
645 50 29
639 52 29
1862 55 27
1209 55 27
732 50 25
635 52 25
822 50 25
439 50 25
419 51 25
932 58 25
843 50 25
1555 52 25
619 58 25
Table 2 – Antibiotic susceptibility characteristics of E.
faecalis. Susceptibility (S) and resistance (R) MIC break-
points (mg/mL) as recommended by CLSI (2011): penicillin
(=8 S, I16 R); erythromycin (=0.5 S, I8 R); tetracycline
(=4 S, I16 R) and vancomycin (=4 S, I32 R).
Isolate MIC (mg/mL)
Penicillin G Erythromycin Tetracycline Vancomycin
1 2(S) 0.25(S) >64(R) 4(S)
2 2(S) 0.25(S) >64(R) 4(S)
3 2(S) 0.25(S) 1(S) 2(S)
4 2(S) 0.25(S) 16(S) 2(S)
5 2(S) 0.25(S) 4(S) 2(S)
6 2(S) 0.25(S) 4(S) 2(S)
7 2(S) 0.25(S) >64(R) 2(S)
8 2(S) 0.25(S) >64(R) 4(S)
9 2(S) 0.25(S) >64(R) 4(S)
10 2(S) 0.25(S) >64(R) 4(S)
11 2(S) 0.25(S) >64(R) 2(S)
12 2(S) 0.25(S) >64(R) 4(S)
13 2(S) 0.25(S) 4(S) 2(S)
14 2(S) 0.25(S) 4(S) 1(S)
15 2(S) 0.25(S) >64(R) 4(S)
16 2(S) 0.25(S) >64(R) 4(S)
17 2(S) 0.25(S) >64(R) 4(S)
18 2(S) 0.25(S) >64(R) 2(S)
19 2(S) 0.25(S) >64(R) 2(S)
20 2(S) 0.25(S) >64(R) 2(S)
Total (%) 0 0 75 0
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3.1. E. faecalis isolates
A total of 20 E. faecalis isolates were recovered from the 43
patients studied following use of the selective medium for
Enterococcus.
3.2. Antibiotic susceptibility
All isolates were deemed susceptible to penicillin G and
erythromycin, being inhibited by 2 and 0.25 mg/mL, respec-
tively (Table 2).30 All isolates were susceptible to vancomycin,
with MICs raging from 1 to 4 mg/mL. However, 9 of these
‘susceptible’ isolates did exhibit MICs of 4 mg/mL to vancomy-
cin, and this is the resistance breakpoint concentration. An
MIC above 4 mg/mL, i.e. between 8 mg/mL and 16 mg/mL would
result in isolates being classed as having ‘intermediate
resistance’ to vancomycin. Fourteen strains (Table 2) were
resistant to tetracycline, with MICs >64 mg/mL, representing
70% of the isolates.
3.3. Detection of antimicrobial resistance and virulence
genes
PCR products for tetracycline resistance were detected in
several test isolates and the relative prevalence of these genes
are presented in Table 3.30 The tetM gene was detected in 12
isolates, whilst tetL was present in 4 isolates, representing 60%
and 20% of the isolates, respectively. The ermA, ermB, vanA,
vanB, vanC1 and vanC2/3 genes were not detected in any tested
isolates (Table 3).
PCR for specific virulence genes (Table 3) showed that all 20
isolates (100%) were positive for gelatinase (gelE), whilst
enteroccocal surface protein (esp) gene was detected for 13
isolates (65%), and aggregation substance (agg) gene was found
in 18 isolates (90%). All isolates were negative for the asa373
(aggregation substance) gene and cytolysin (cylB) gene.
4. Discussion
Despite the microbiome of primary and post treatment
endodontic infections being extensively studied, the main
aetiological agents remain unclear. There is evidence support-
ing an association of enterococci, particularly E. faecalis with
both primary and secondary endodontic infection.2–8 Reports
on E. faecalis prevalence in root canals can vary considerably,
possibly due to differences in methods of clinical sampling
and analysis. In teeth exhibiting failed endodontic treatment,
previous studies report an E. faecalis prevalence of between
18.5–70% when culture is used, and 67–89.6% using PCR
detection.5,7,14,16,31–33 However, in cases of primary endodontic
infection, prevalence is lower, ranging between 4–12.5% with
culture and 33–89.3% using PCR.7,8,14,16 In this study, a high
prevalence of E. faecalis was noted (20/43 patients), and the
exact reasons for this remain unclear. There are several
factors that could have been responsible for this high recovery
which may relate to the demographics of the patients studiedand the possible high recovery based on use of an Enterococcus
selective isolation medium. The observed high prevalence,
does however, highlight the importance of continuous
surveillance of E. faecalis at various sampling sites and the
impact of population demographics that could influence
microbial communities such as these.
The origin and role of enterococci in the pathogenesis of
endodontic infection is also unclear.7,12,17,34–36 Regarding the
role of enterococci in endodontic infection, we believe that
knowledge of bacterial virulence factors involved in the
pathogenesis of apical periodontitis is fundamental to
understanding the disease process and to assist in establish-
ing appropriate treatment, motivating us to characterise the
endodontic isolates both genotypically and phenotypically.
In the present study, antimicrobial susceptibility was
determined for all endodontic isolates, and revealed a high
prevalence of tetracycline resistance (70%), exceeding
previously reported findings.2,18,37 The incidence does however,
appear to be increasing, for example, between 2000 and 2010,
several studies have reported E. faecalis from endodontic
infections to exhibit resistance to tetracycline at levels
increasing from 14.3%, 15.1%, 28.8% and 30% according to
Pinheiro et al.,38 Sedgley et al.,19 Reynaud af Geijersstam et al.,39
and Skucaite et al.,40 respectively.
Kuch et al.41 analysed antimicrobial susceptibility of 386 E.
faecalis isolates from hospitals and communities of six
European countries. The percentage of resistance to tetracy-
cline was 77.9% for hospital isolates and 55.6% for community
isolates. In our study, we have therefore encountered a higher
prevalence of tetracycline in endodontic isolates compared to
those previously noted for community isolates.
Table 3 – Genetic profiles of E. faecalis from primary endodontic infection in Brazil.
Isolate Antimicrobial resistance genes Virulence genes
ermA ermB tet
M
tet
L
vanA vanB van
C1
van
C2/3
gelE esp agg asa
373
cylB
1   +      + + +  
2         + + +  
3         + + +  
4         +  +  
5         +  +  
6         +  +  
7   + +     +  +  
8   +      + + +  
9   +      + + +  
10   +      + + +  
11         +  +  
12   +      + + +  
13         + +   
14         +    
15   +      + +   
16   +      + +   
17   +      + +   
18   + +     +  +  
19   + +     + + +  
20   + +     + + +  
Total (%) 0 0 60 20 0 0 0 0 100 65 90 0 0
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endodontic isolates may be explained by selective pressure
due to previous use of tetracyclines in the practice of dentistry,
such as in the treatment of localised aggressive periodontitis
and as an intracanal medication. In a longitudinal study over
12 months, Rodrigues et al.42 observed the antibiotic resis-
tance profile of subgingival microbiota following systemic and
local administration of tetracycline as an adjunct to periodon-
tal therapy. In all cases where tetracycline was used, there was
an initial selection of drug-resistant microorganisms, and only
after months of continuous treatment, particularly topically
and at high concentrations was their prevalence reduced. This
fact demonstrates that short-term use of such intracanal
medication may promote prevalence of resistant strains at the
site of infection.
In endodontics, several studies have assessed the antimi-
crobial efficacy of antibiotic mixtures containing ciprofloxa-
cin, metronidazole, and minocycline against the pathogens
commonly found inside the root canal system including E.
faecalis. This triple antibiotic mixture is also promoted as an
intracanal medicament to disinfect the root canal system to
encourage revascularization of a tooth with a necrotic pulp.43
Antibiotics have been suggested as possible irrigants by
Torabinejad et al.44 and Giardino et al.45 with both of these
studies including tetracycline within their irrigant formula-
tions. Tetracycline is also present in Ledermix paste (Haupt
Pharma GmbH, Wolfratshausen, Germany), a combination of
the same tetracycline antibiotic, demeclocycline HCl (3.2%),
and a corticosteroid, triamcinolone acetonide (1%), in a
polyethylene glycol base, which is advocated as an intracanal
dressing in cases of pulp-less infected root canals, pulp
necrosis and infection with incomplete root formation
(apexification), perforations, inflammatory root resorption,
inflammatory periapical bone resorption, and for the treat-
ment of large periapical radiolucent lesions. Thus, the localuse of tetracycline in endodontic infection is still being utilised
in some cases, and may contribute to an increase in resistance
to this antibiotic by exposed isolates.
PCR products for tetracycline resistance genes were also
detected in our study, with the tetM gene being evident in 12
isolates and tetL in 4 isolates, representing 60% and 20% of the
samples. There was a direct correlation of 85% between the
presence of the tetM and antibiotic susceptibility test result (12
of 14 tetracycline resistant isolates were positive to tetM)
indicating that PCR analysis may be an important marker for
screening antibiotic resistance. Villedieu et al.46 also found a
high prevalence of 79% for the gene tetM in oral bacteria
isolated from dental plaque and saliva.
Tetracycline resistance in clinical isolates of enterococci is
frequently associated with plasmids and/or conjugative
transposons47 which can readily be transferred between
species.48
The conditions in root canals of low nutrient levels and the
presence of antimicrobials agents limit sensitive strains and
select for more resistant species such as E. faecalis. Multiple
antibiotic resistance in clinical isolates of E. faecalis from root
canal infections has been reported,19,38,39,49 as well as the
transfer of antibiotic resistance genes between these bacteria
and related species.22,50 Although our study did not find multi-
resistant isolates, or VRE, the possibility that these strains
could occur in root canals infections cannot be excluded. In
our study, 9 isolates (45%) had MICs of 4 mg/mL to vancomycin
which is at the resistance breakpoint for this agent. This result
motivated our investigation of the most common genes
related to resistance to vancomycin in enterococci, namely,
vanA, vanB, vanC1 and vanC2/3, which were not detected, thus
confirming the MIC results of the present study and those
previously reported.19,21,35,49 However, Nandakumar et al.23
found proteins from the tet and van operons to be predominant
in all patient cases where enterococci were detected by
j o u r n a l o f d e n t i s t r y 4 1 ( 2 0 1 3 ) 7 7 9 – 7 8 6784genomic analysis. ErmA and ermB genes were not detected in
our endodontic isolates, thus correlating with the phenotypic
results of susceptibility in the MIC test. These findings were
also in agreement with the work of Sedgley et al.19
There is ongoing debate regarding the relative merits of
using local antibiotics to treat oral infections, particularly
given the inability of many antibiotics to penetrate bio-
films.51,52 New approaches have been proposed for biofilm
control by blocking adherence or co-aggregation mechanisms,
disruption of quorum-sensing mechanisms and probiotic
therapy.53 An understanding of the interactions between
the microorganisms and which are the virulence factors
involved, provides opportunities for novel ‘non-antibiotic’
methods of control. In this context, we also investigated a
number of virulence genes described in oral E. faecalis,
including cytolysin (cylB), enterococcal surface protein (esp),
gelatinase (gelE) and aggregation substances (agg and asa373).
Cytolysin is a haemolytic toxin that also has bacteriocin
activity54; ESP is a surface protein that enhances biofilm
formation by E. faecalis,55 and gelatinase is a metalloprotease
that cleaves several substrates including insoluble collagen
fragments, as well as the pheromone and inhibitor peptides
involved in conjugative plasmid transfer of E. faecalis. A role for
gelE in biofilm development has also been described.56
Aggregation substance is a pheromone-inducible surface
protein that promotes aggregation during bacterial conjuga-
tion. This virulence trait and others factors, including
cytolysin and ESP were found to be encoded on a large, 153-
kb pathogenicity island.57
In our study, the gelE was detected in all isolates, whilst esp
was detected in 13 isolates (65%), and agg was evident for 18
isolates (90%). As these virulence determinants have been
shown to influence biofilm formation58 they may play a role in
promoting the persistence of enterococci in the root canal
environment.
Wang et al.20 analysed the relationship of biofilm formation
and gelE gene expression in E. faecalis recovered from root
canals and found higher expression in cases of apical
radiolucency and in biofilm forming isolates. These authors
suggested that high expression of gelE may contribute to the
development of apical periodontitis. Although gelatinase
production in vitro was not examined in our study, other
studies have related expression to a determinant (ef1841/fsrC)
of a deletion sequence of the fsr gene cluster, the quorum
sensing system that regulate the expression of gelE gene.
Gelatinase-negative phenotype is related to the presence of
this determinant.25
5. Conclusion
In summary, this study demonstrated a high incidence of
tetracycline resistance (an antibiotic that is still used in local
treatment of oral infections) in E. faecalis isolates from primary
endodontic infections. This opens up a much needed debate
on the role and efficacy of this antibiotic for endodontic
infections. Furthermore, isolates were shown to possess genes
that could contribute to their pathogenicity in the pulp cavity,
and which can also be transferred in the microenvironment of
the root canal. Clearly, more research in this area is requiredparticularly in relation to the possession and expression of
virulence factors in the root canal environment, to better
inform our management strategies. Environmental pressure
in root canals may be responsible for the selection of more
resistant species and the possession of virulence determi-
nants. This knowledge is important in guiding procedures for
controlling the increasing problem of antibiotic resistance
amongst clinically relevant bacteria.
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